Grufity logoGrufity logo
Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists

Latest Stonepine Capital Management, LLC Stock Portfolio

$126Million

Equity Portfolio Value
Last Reported on: 15 May, 2024

About Stonepine Capital Management, LLC and it’s 13F Hedge Fund Stock Holdings

Stonepine Capital Management, LLC is a hedge fund based in BEND, OR. On 08-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $271.5 Millions. In it's latest 13F Holdings report, Stonepine Capital Management, LLC reported an equity portfolio of $126.1 Millions as of 31 Mar, 2024.

The top stock holdings of Stonepine Capital Management, LLC are EOLS, ADMA, ALIM. The fund has invested 29.7% of it's portfolio in EVOLUS INC and 17.9% of portfolio in ADMA BIOLOGICS INC.

The fund managers got completely rid off AMYLYX PHARMACEUTICALS INC (AMLX), QUIDELORTHO CORP (QDEL) and ATEA PHARMACEUTICALS INC (AVIR) stocks. They significantly reduced their stock positions in REZOLUTE INC (RZLT), SCYNEXIS INC (SCYX) and IO BIOTECH INC (IOBT). Stonepine Capital Management, LLC opened new stock positions in REVANCE THERAPEUTICS INC (RVNC), NEKTAR THERAPEUTICS (NKTR) and MILESTONE PHARMACEUTICALS IN (MIST). The fund showed a lot of confidence in some stocks as they added substantially to TELA BIO INC (TELA), GALAPAGOS NV-SPON ADR (GLPG) and XOMA CORP (XOMA).

New Buys

Ticker$ Bought
REVANCE THERAPEUTICS INC9,723,600
NEKTAR THERAPEUTICS3,251,400
MILESTONE PHARMACEUTICALS IN2,617,510
SCPHARMACEUTICALS INC2,242,820
CALCIMEDICA INC2,174,020
ANIKA THERAPEUTICS INC1,548,100
RIGEL PHARMACEUTICALS INC1,539,560
ADICET BIO INC332,638
New stocks bought by Stonepine Capital Management, LLC

Additions

Ticker% Inc.
TELA BIO INC116
GALAPAGOS NV-SPON ADR50.32
XOMA CORP1.51
ALIMERA SCIENCES INC1.29
Additions to existing portfolio by Stonepine Capital Management, LLC

Reductions

Ticker% Reduced
REZOLUTE INC-95.61
SCYNEXIS INC-92.94
IO BIOTECH INC-90.63
XERIS BIOPHARMA HOLDINGS INC-89.93
ADMA BIOLOGICS INC-62.84
EVOLUS INC-49.85
EXAGEN INC-42.57
Stonepine Capital Management, LLC reduced stake in above stock

Sold off

Ticker$ Sold
AMYLYX PHARMACEUTICALS INC-36,800,000
ATEA PHARMACEUTICALS INC-2,560,520
ATYR PHARMA INC-679,984
QUIDELORTHO CORP-33,165,000
Stonepine Capital Management, LLC got rid off the above stocks

Current Stock Holdings of Stonepine Capital Management, LLC

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
ACETADICET BIO INC0.26141,548332,638NEW
ADMAADMA BIOLOGICS INC17.943,426,88022,617,400REDUCED-62.84
ALIMALIMERA SCIENCES INC12.534,051,07015,799,200ADDED1.29
AMLXAMYLYX PHARMACEUTICALS INC0.000.000.00SOLD OFF-100
ANIKANIKA THERAPEUTICS INC1.2360,9491,548,100NEW
AVIRATEA PHARMACEUTICALS INC0.000.000.00SOLD OFF-100
AYTUAYTU BIOPHARMA INC1.14472,4691,436,310UNCHANGED0.00
EOLSEVOLUS INC29.702,674,36037,441,000REDUCED-49.85
GLPGGALAPAGOS NV-SPON ADR10.05393,63412,675,000ADDED50.32
IOBTIO BIOTECH INC0.21156,167270,169REDUCED-90.63
LIFEATYR PHARMA INC0.000.000.00SOLD OFF-100
MISTMILESTONE PHARMACEUTICALS IN2.081,462,3002,617,510NEW
NKTRNEKTAR THERAPEUTICS2.583,480,4103,251,400NEW
QDELQUIDELORTHO CORP0.000.000.00SOLD OFF-100
RIGLRIGEL PHARMACEUTICALS INC1.221,040,2401,539,560NEW
RVNCREVANCE THERAPEUTICS INC7.711,976,3409,723,600NEW
RZLTREZOLUTE INC0.25121,479309,771REDUCED-95.61
SCPHSCPHARMACEUTICALS INC1.78446,7762,242,820NEW
SCYXSCYNEXIS INC0.1195,637140,586REDUCED-92.94
TELATELA BIO INC3.10688,2003,902,090ADDED116
XERSXERIS BIOPHARMA HOLDINGS INC1.05598,0861,321,770REDUCED-89.93
XGNEXAGEN INC0.48384,600611,514REDUCED-42.57
XOMAXOMA CORP4.84253,7706,103,170ADDED1.51
CALCIMEDICA INC1.73522,6022,174,020NEW